Cancer and viral infections in immunocompromised individuals.
about
A niche for infectious disease in environmental health: rethinking the toxicological paradigmCan tissue-based immune markers be used for studying the natural history of cancer?Incidence, risk factors and outcomes of de novo malignancies post liver transplantationLiver transplantation: immunosuppression and oncologyTwenty years of KSHVStrategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantationViral surveillance and discoveryThe concept of immune surveillance against tumors. The first theoriesEpstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73αMicroenvironmental regulation of tumor progression and metastasisγ-Radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivoViruses and human cancer: from detection to causality.Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case-control studyCommon Commensal Cancer Viruses.Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphomaAssessment of antibody titers and immunity to Hepatitis B in children receiving chemotherapy.EBV-associated hepatic smooth muscle tumor of uncertain biologic behavior after heart transplantation in a pediatric patient: case report.Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma.Post-transplantation lymphoproliferative disorder (PTLD) twenty years after heart transplantation: a case report and review of the literature.Do cannabinoids have a therapeutic role in transplantation?Why do viruses cause cancer? Highlights of the first century of human tumour virology.Emerging topics in human tumor virology.Update on imaging of non-infectious musculoskeletal complications of HIV infection.The molecular genetics of eyelid tumors: recent advances and future directions.Epstein-Barr virus-associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient.Does the immune system naturally protect against cancer?Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort.Checkpoint inhibition for colorectal cancer: progress and possibilities.Development of a squamous cell carcinoma mouse model for immunotoxicity testing.Cancer risks after solid organ transplantation and after long-term dialysis.Prospective study of Merkel cell polyomavirus and risk of Merkel cell carcinoma.Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice.Viruses in cancers among the immunosuppressed.The correlation between renal transplantation and liver carcinoma: a meta-analysis.Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients.Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy.Merkel cell carcinoma with divergent differentiation: histopathological and immunohistochemical study of 15 cases with PCR analysis for Merkel cell polyomavirus.The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study.Cytogenetic and immunological effects associated with occupational formaldehyde exposure.Extension of the viral ecology in humans using viral profile hidden Markov models.
P2860
Q23910406-2F21C619-E774-4AC9-994E-6FAF6CD36052Q24605537-3577D3A3-40CE-4700-8DC2-489ED8CE2E33Q26748580-12ECB2F6-2156-47DC-AC78-8464DF9456C6Q26827252-085688E7-249F-44EE-B80A-E084C0BD7112Q26999889-69DD7F75-E26E-4EB1-BCC6-82FBEEED6C2CQ27005375-BE62D071-E5A4-4A84-B0E8-9F75A6A41986Q27016083-262C7D6E-2D73-41D6-835D-22166BC31CABQ28073937-B739977A-8229-4D32-83DB-191032BE5264Q28487983-AFEF80EE-5AF9-4AE7-A01A-AA32C3055EFCQ29615504-02205097-6B81-4526-B9DE-195909F10822Q34091374-395E5FA3-CCB1-4E35-BD11-400D1411903EQ34567612-688F6743-D414-47F1-9D87-A5F438A18BD0Q36236011-32EB5244-40D2-44E4-B264-0C690A3F241FQ36254085-DB11C914-DC01-47FF-AA54-0B31D9E604EBQ36622888-E7301DC7-00E7-4D05-8967-4ACECAC8CBDEQ37560071-2FC63013-985F-47DD-A677-D01ED6B105DBQ37677567-3645B3A3-4AB7-4566-BF58-C3E60F7B09F4Q37721811-7E173365-090A-44DA-94AF-43643984FF17Q37730638-088A5F80-EDB6-47FA-96E8-7776CDF3EEECQ37768965-F4C108EA-9CE1-44F3-A76B-9EB6487FF374Q37811898-D32F2F7C-8837-4696-8002-5520714A6141Q37858935-253776CA-EE50-4043-864C-D810FBB33FB8Q38012380-A8B9D008-D023-4BAF-9C8F-D8B627929D1AQ38070357-513246F4-4832-4651-B177-034E03412A31Q38137320-17624FA3-64D9-4066-92F6-19490541893EQ38214640-8CE35220-BB13-4C9C-B112-B3880E1519B2Q38425202-43F4DD8E-20AC-4E32-99B6-11C27DEB2725Q38838641-075166D9-0AE3-4091-B423-9FAFF37FDD3DQ38871984-5373A1CA-C6F0-4059-B055-ED2B80A7D8C2Q39168542-D9F0E8C3-40A9-4441-BEC3-81891E18FEA3Q39371247-EA98179F-A646-4550-9955-BC59F4F14FC6Q39402703-0091915E-FD7E-43DD-B665-E5408587D834Q40070529-15FB9D1A-4BEF-4C2E-89EE-1CCC099A656FQ41924348-4AE88058-0D36-4EA8-8D57-AEB1E2D31167Q42245249-24BEFBAB-8259-480C-B94F-E08874216493Q43169264-8DBA9E24-231C-4A53-9373-4D0D2E215170Q43777103-FF298E47-440D-4B3D-8025-72CD8949AE8BQ44626217-1CF8074C-4804-42B7-BE4A-B1837DE150C0Q46764302-5917BC0A-A32E-4619-9031-928A57F703A4Q47551270-0E6FEB58-880D-4996-8E39-AED122C85080
P2860
Cancer and viral infections in immunocompromised individuals.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer and viral infections in immunocompromised individuals.
@en
Cancer and viral infections in immunocompromised individuals.
@nl
type
label
Cancer and viral infections in immunocompromised individuals.
@en
Cancer and viral infections in immunocompromised individuals.
@nl
prefLabel
Cancer and viral infections in immunocompromised individuals.
@en
Cancer and viral infections in immunocompromised individuals.
@nl
P356
P1476
Cancer and viral infections in immunocompromised individuals.
@en
P2093
Thomas F Schulz
P304
P356
10.1002/IJC.24741
P577
2009-10-01T00:00:00Z